Literature DB >> 22298791

What is meant by active disease in the NICE recommendation on use of combination therapy in early RA?

Carsten Ezard, Rakesh Kumari, Ruth Willott, Sayqa Butt, Kate Gadsby, Chris Deighton.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22298791     DOI： 10.1093/rheumatology/ker513

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  1 in total

1.  A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study.

Authors:  Alexander M Lila; Vadim I Mazurov; Lev N Denisov; Olga B Nesmeyanova; Elena P Ilivanova; Anna V Eremeeva; Julia Valentinovna Usacheva; Ekaterina A Dokukina; Ekaterina V Chernyaeva; Roman A Ivanov
Journal:  Rheumatol Int       Date:  2019-07-10       Impact factor: 2.631
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.